"Adenosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
| Descriptor ID |
D000241
|
| MeSH Number(s) |
D03.633.100.759.590.138 D13.570.583.138 D13.570.800.096
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenosine".
Below are MeSH descriptors whose meaning is more specific than "Adenosine".
This graph shows the total number of publications written about "Adenosine" by people in this website by year, and whether "Adenosine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 2 | 2 |
| 1994 | 1 | 2 | 3 |
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 2 | 4 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 2 | 2 | 4 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 1 | 4 |
| 2008 | 2 | 3 | 5 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 2 | 4 |
| 2012 | 2 | 5 | 7 |
| 2013 | 5 | 0 | 5 |
| 2014 | 2 | 4 | 6 |
| 2015 | 7 | 1 | 8 |
| 2016 | 8 | 5 | 13 |
| 2017 | 9 | 3 | 12 |
| 2018 | 10 | 3 | 13 |
| 2019 | 13 | 0 | 13 |
| 2020 | 9 | 3 | 12 |
| 2021 | 4 | 3 | 7 |
| 2022 | 2 | 4 | 6 |
| 2023 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenosine" by people in Profiles.
-
Inter-species association mapping links splice site evolution to METTL16 and SNRNP27K. Elife. 2023 10 03; 12.
-
Mammalian DNA N6-methyladenosine: Challenges and new insights. Mol Cell. 2023 02 02; 83(3):343-351.
-
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascul Pharmacol. 2023 02; 148:107143.
-
Transcriptome-wide profiling and quantification of N6-methyladenosine by enzyme-assisted adenosine deamination. Nat Biotechnol. 2023 Jul; 41(7):993-1003.
-
RNA editing underlies genetic risk of common inflammatory diseases. Nature. 2022 08; 608(7923):569-577.
-
FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development. Science. 2022 05 27; 376(6596):968-973.
-
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States. Liver Transpl. 2022 09; 28(9):1454-1462.
-
The regulatory role of N6 -methyladenosine modification in the interaction between host and microbes. Wiley Interdiscip Rev RNA. 2022 11; 13(6):e1725.
-
Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction? J Thorac Oncol. 2022 03; 17(3):e35-e38.
-
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy. J Immunother Cancer. 2022 02; 10(2).